In Vivo Imaging of Hypoxia Associated with Inflammatory Bowel Disease by Cytoplasmic Protein-Powered Fluorescence Cascade Amplifier
In Vivo Imaging of Hypoxia Associated with Inflammatory Bowel Disease by Cytoplasmic Protein-Powered Fluorescence Cascade Amplifier
复制标题
通过细胞质蛋白驱动的荧光级联放大器对与炎症性肠病相关的缺氧进行体内成像
DOI:
10.1021/acs.analchem.9b05278
复制
发表时间:
2020
影响因子:
7.4
通讯作者:
Ronghua Yang
中科院分区:
文献类型:
--
作者:
Yibo Zhou;Sheng Yang;Jingru Guo;Hao Dong;Keyi Yin;Wei Tao Huang;Ronghua Yang
Accurate and sensitive imaging of hypoxia associated with inflammatory bowel disease (IBD) is significant for the precise diagnosis and treatment of this disease, but it remains a challenge for traditional hypoxia-activatable fluorescence probes because of a more moderate hypoxic state during IBD than under other pathological conditions. To address this issue, herein, we designed a hypoxia-activatable and cytoplasmic protein-powered fluorescence cascade amplifier, named HCFA, to image hypoxia associated with IBDin vivo. In our design, a 4-aminobenzoic acid (azo)-modified mesoporous silica nanoparticle (MSN) was used as a container to load black hole quencher 2 (BHQ2) and cytoplasmic protein-binding squarylium dye (SQ); then, the β-cyclodextrin polymer (β-CDP) combined with azo through a host–guest interaction to form HCFA. Upon passive stagnation in the inflamed tissue of IBD, the azo band would be cleaved under a hypoxic microenvironment, and SQ was released to activate the fluorescence of HCFA. Moreover, the unconstrained SQ can bind with cytoplasmic protein to exhibit drastic fluorescence intensity enhancement, realizing the fluorescence signal amplification for imaging of hypoxia. When one takes advantage of the large load capacity of MSN and the unique property of SQ, HCFA can sense oxygen levels in the range of 0% to 10%. Meanwhile, the fluorescence imaging results demonstrate that HCFA can sensitively distinguish different levels of cellular hypoxia and monitor the variations of hypoxiain vivo, highlighting HCFA as a promising tool for the detection of hypoxia associated with IBD.